Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Microbiology Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Microbiology Meet 2024

About Conference


Join us for the MICROBIOLOGY MEET 2024 in Prague, Czech Republic, on December 02-03, 2024. "Theme: Novel Advances and Therapeutic Insights in Clinical Microbiology & Infectious Diseases" 

This international conference provides a platform for scientists, researchers, professors, engineers, and students in microbiology, virology, infectious diseases, and related fields to share knowledge and discuss advancements.

Microbiology Meet 2024 focuses on research and therapeutic findings in microbial diseases, viruses, and infections caused by bacteria, fungi, and protists. It addresses issues such as waterborne, foodborne, and airborne diseases in humans, plants, and animals. The conference highlights the crucial role of microbes in solving global health challenges, emphasizing the importance of vaccination and vaccine development.

Target Audience:

  • Directors, Board Members, Presidents, Vice Presidents
  • Deans and Department Heads
  • Business Entrepreneurs and Industrialists
  • Microbiologists, Virologists, Parasitologists, Bacteriologists
  • Pharmacists, Epidemiologists, Dermatologists, Neurologists, Ophthalmologists, Cardiologists
  • Researchers, Scientists, Faculty, Students in Infectious Diseases
  • Infectious Diseases Associations and Societies
  • Medical Colleges, Hospitals & Labs
  • Pharmaceutical and Medical Devices Companies
  • Laboratory Technicians and Diagnostic Companies

Don't miss this opportunity to update your skills, enhance your knowledge, and network with professionals from around the world.

Sessions/ Tracks

Session 01: Bacterial and Fungal Infectious Diseases

Bacterial and fungal infectious diseases pose a significant health challenge, caused by pathogenic bacteria and fungi. These infections, such as strep throat and athlete's foot, vary in symptoms and complications. Treatment typically involves antibiotics for bacterial infections and antifungal medications for fungal ones. However, rising antibiotic resistance and emerging fungal pathogens complicate management. Healthcare professionals must remain vigilant in diagnosing, treating, and preventing these infections.

  • Pathogenic bacteria
  • Fungal pathogens
  • Antibiotic resistance
  • Antifungal medications
  • Infectious diseases management

Session 02: Waterborne Infectious Diseases

Waterborne infectious diseases, caused by pathogens in contaminated water, pose significant health risks. These diseases, transmitted through ingestion, inhalation, or contact, include gastroenteritis, cholera, hepatitis, and cryptosporidiosis. Key pathogens are bacteria, viruses, and parasites. Effective water treatment and sanitation measures are crucial for prevention.

  • Waterborne pathogens
  • Contaminated water
  • Waterborne illness
  • Water purification
  • Hygiene practices

Session 03: Nosocomial infections

Nosocomial infections, also termed healthcare-associated infections, are those acquired during medical care within healthcare facilities. Common types include urinary tract infections, surgical site infections, and pneumonia. They are typically caused by bacteria, viruses, or fungi and can result from factors like poor hand hygiene and contaminated medical equipment. Prevention measures, including strict infection control practices and antimicrobial stewardship, are crucial for reducing their occurrence and safeguarding patients' well-being.

  • Hospital-acquired infections
  • Infection control measures
  • Antibiotic resistance in healthcare settings

Session 04: STD and HIV Infections

Sexually transmitted diseases (STDs) and human immunodeficiency virus (HIV) infections are significant public health concerns worldwide. STDs are infections spread through sexual contact and can include diseases such as chlamydia, gonorrhea, syphilis, and genital herpes. HIV is a virus that attacks the body's immune system, leading to acquired immunodeficiency syndrome (AIDS) if left untreated. Both STDs and HIV can have serious health consequences if not diagnosed and managed appropriately. Prevention strategies, including safe sexual practices, regular testing, and access to education and healthcare services, are essential for reducing the transmission and impact of STDs and HIV infections.

  • Safe sex practices
  • STI screening and testing
  • Contraception methods
  • HIV/AIDS awareness and education

Session 05: Blood Infectious Diseases

Blood infectious diseases are infections caused by pathogens that directly affect the bloodstream. These diseases can include bacterial bloodstream infections (sepsis), viral infections such as hepatitis B and C, and parasitic diseases like malaria. They are often transmitted through blood transfusions, contaminated needles, or insect bites. Diagnosis typically involves blood tests to identify the causative agent. Prompt treatment is crucial to prevent complications such as organ damage and systemic infection. Prevention strategies focus on blood safety measures, vaccination, and vector control in endemic areas.

  • Bloodborne pathogens
  • Blood transfusion safety
  • Viral hepatitis

Session 06: Ebola and Zika Viral Infections

Ebola and Zika viruses are significant global health concerns due to their potential for outbreaks and severe health consequences. Ebola virus disease is a severe illness with a high mortality rate, primarily affecting communities in Central and West Africa. Zika virus, transmitted by mosquitoes, can lead to neurological complications and birth defects like microcephaly. Prevention efforts include vector control measures and public health interventions to limit transmission.

  • Ebola virus
  • Zika virus
  • Viral hemorrhagic fever
  • Epidemic
  • Mosquito-borne diseases

Session 07: Paediatric infectious disease

Pediatric infectious diseases encompass a wide range of illnesses affecting children, from common colds to serious conditions like meningitis and pneumonia. Children are often more susceptible to infections due to their developing immune systems. Diagnosis and treatment of pediatric infectious diseases require specialized care and consideration of factors like age and immunization status.

  • Pediatric infections
  • Childhood illnesses
  • Pediatric immunization
  • Pediatric vaccination
  • Pediatric infectious disease specialists

Session 08: Infectious Diseases & Infection control

Effective infection control practices are essential for preventing the spread of infectious diseases in healthcare settings and the community. This includes measures such as hand hygiene, proper use of personal protective equipment, and sterilization of medical equipment. Surveillance and monitoring of infections help identify outbreaks and implement timely interventions to limit transmission.

  • Communicable diseases
  • Pathogens
  • Transmission
  • Hygiene
  • Disease prevention

Session 09: Severe acute respiratory syndrome (SARS)

SARS is a viral respiratory illness caused by the SARS coronavirus. It emerged in 2002-2003, leading to a global outbreak with significant morbidity and mortality. SARS is characterized by flu-like symptoms and can progress to severe respiratory distress. Prevention measures involve quarantine, travel restrictions, and infection control protocols to contain outbreaks.

  • SARS coronavirus
  • Respiratory infections
  • Pandemic
  • Respiratory distress
  • Quarantine measures

Session 10: Gastrointestinal infections

Gastrointestinal infections affect the digestive system and can be caused by bacteria, viruses, or parasites. Common examples include norovirus, salmonella, and E. coli infections. Symptoms may include diarrhea, vomiting, abdominal pain, and fever. Treatment typically involves hydration, rest, and, in some cases, antibiotics for bacterial infections. Prevention focuses on food safety and proper hygiene practices.

  • Gastroenteritis
  • Foodborne illnesses
  • Diarrheal diseases
  • Enteric infections
  • Stomach flu

Session 11: Disinfection and Sterilization

Disinfection and sterilization are crucial processes for eliminating microorganisms from surfaces, medical equipment, and instruments. Disinfection reduces the number of microorganisms to a safe level, while sterilization eliminates all microbial life, including bacteria, viruses, and fungi. These practices are essential in healthcare settings to prevent healthcare-associated infections and ensure patient safety.

  • Sterilization methods

  • Disinfection techniques

  • Autoclaving

  • Chemical disinfectants

  • Infection control measures

Session 12: Neuro infectious diseases

Neuroinfectious diseases are caused by pathogens that invade the nervous system, leading to conditions such as meningitis, encephalitis, and brain abscesses. These infections can be caused by bacteria, viruses, fungi, or parasites and may result in neurological complications or long-term damage. Diagnosis involves imaging studies and cerebrospinal fluid analysis, while treatment may include antimicrobial therapy and supportive care.

  • Meningitis

  • Encephalitis

  • Brain infections

  • Neurological complications

  • Central nervous

Session 13: Vaccines and Vaccination

Vaccines are critical tools for preventing infectious diseases by stimulating the immune system to produce protective antibodies against specific pathogens. Vaccination programs have led to the eradication or significant reduction of many infectious diseases worldwide, saving millions of lives. Vaccine development involves rigorous testing for safety and efficacy before implementation in vaccination campaigns.

  • Immunization

  • Vaccine development

  • Vaccine efficacy

  • Herd immunity

  • Vaccine safety

Session 14: Virology

Virology is the study of viruses, including their structure, classification, replication, and interactions with host cells. Understanding virology is essential for developing antiviral drugs, vaccines, and diagnostic tests for viral infections. Advances in virology have contributed to the control and prevention of viral diseases and the development of novel therapeutics.

  • Viruses

  • Viral replication

  • Viral pathogenesis

  • Viral diseases

  • Molecular virology

  • Diagnostic virology

 

Session 15: Virology and Gene Therapy

Virology intersects with gene therapy, a promising approach for treating genetic disorders and certain cancers. Viruses can be engineered to deliver therapeutic genes into target cells, offering potential cures for previously incurable diseases. Research in virology and gene therapy continues to advance, paving the way for innovative treatments and personalized medicine.

  • Gene delivery vectors

  • Viral vectors

  • Gene editing

  • Gene therapy applications

  • Genetic diseases

  • Viral gene transfer

Session 16: Microbiology & Immunology

Microbiology and immunology are closely related fields that study microorganisms and the immune system, respectively. Microbiologists investigate the biology of bacteria, viruses, fungi, and parasites, while immunologists focus on understanding the body's defense mechanisms against infections. The synergy between microbiology and immunology is essential for understanding infectious diseases and developing effective treatments and vaccines.

  • Microorganisms

  • Immune system

  • Host-pathogen interactions

  • Microbial infections

  • Immunological disorders

  • Microbial genetics

Session 17: Hepatitis C & Coronavirus (COVID-19)

Hepatitis C and coronavirus (COVID-19) are viral infections with distinct characteristics and impacts on public health. Hepatitis C is a bloodborne virus that can lead to chronic liver disease and liver cancer if left untreated. COVID-19, caused by the novel coronavirus SARS-CoV-2, emerged in late 2019, resulting in a global pandemic with millions of cases and deaths worldwide. Understanding the epidemiology, transmission, and management of these infections is critical for controlling their spread and reducing their burden on healthcare systems.

 

 

  • HCV

  • SARS-CoV-2

  • Viral hepatitis

  • COVID-19 pandemic

  • Antiviral therapy

  • Immune response

 

To Collaborate Scientific Professionals around the World

Conference Date December 02-03, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by